Cited by 475Gastrointestinal motility and disordersAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychosomatic Disorders and Their Treatments

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom‐specific anxiety scale

Open access
Labus, J. S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, E. A., Naliboff, B. D.·2004·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background : Anxiety related to gastrointestinal sensations, symptoms or the contexts in which these may occur is thought to play a significant role in the pathophysiology as well as in the health outcomes of patients with irritable bowel syndrome. Aim : To develop a valid and reliable psychometric instrument that measures gastrointestinal symptom‐specific anxiety. Methods : External and internal expert panels as well as a patient focus group evaluated a large pool of potential item stems gathered from the psychological and gastrointestinal literature. Potential scale items were then administered to 96 patients diagnosed with irritable bowel syndrome along with a set of validating questionnaires. Final item selection was based upon rigorous empirical criteria and the psychometric properties of the final scale were examined. Results : A final unidimensional 15‐item scale, the Visceral Sensitivity Index, demonstrated excellent reliability as well as good content, convergent, divergent and predictive validity. Conclusions : The findings suggest that the Visceral Sensitivity Index is a reliable, valid measure of gastrointestinal symptom‐specific anxiety that may be useful for clinical assessment, treatment outcome studies, and mechanistic studies of the role of symptom‐related anxiety in patients with irritable bowel syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2004.02007.x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [14]14. Asmundson GJG, Norton PJ, Norton GR. Beyond pain: the role of fear and avoidance in chronicity. Clin Psychol Rev 1999; 19: 97-119.
  2. [34]34. Naliboff BD, Munakata J, Chang L, Mayer EA. Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. J Psychosom Res 1998; 45: 485-92.

Cited by

Sorted by citations

Authors
Labus, J. S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, E. A., & Naliboff, B. D.
Affiliations
  • VA Greater Los Angeles Healthcare System (US)
  • AstraZeneca (Sweden) (SE)
  • University of California, Los Angeles (US)
Corresponding author
Mayer, E. A.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2004-06-14
Volume
20
Issue
1
Pages
89-97
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2026222517
Cited by
475
References
43
Citations by year
2026: 31 · 2025: 42 · 2024: 31 · 2023: 32 · 2022: 48 · 2021: 49 · 2020: 32 · 2019: 17 · 2018: 34 · 2017: 23 · 2016: 26 · 2015: 14 · 2014: 21 · 2013: 14 · 2012: 12
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • AstraZeneca
  • National Institute of Nursing Research (R01NR007768, NR007768)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P50DK064539, P-50DK64539)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
irritable bowel syndrome, psychometric scale development, anxiety assessment, visceral sensitivity, scale validation, content validity
MeSH terms
Adult, Aged, Anxiety, Female, Humans, Male, Middle Aged, Predictive Value of Tests, Psychometrics, Quality of Life, Surveys and Questionnaires, Sensitivity and Specificity, Viscera, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review